Ameriprise’s OncoMed Pharmaceuticals, Inc. OMED Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q3 | – | Sell |
-283,220
| Closed | -$654K | – | 3847 |
|
|
2018
Q2 | $654K | Sell |
283,220
-21,100
| -7% | -$48.7K | ﹤0.01% | 3158 |
|
|
2018
Q1 | $968K | Sell |
304,320
-656,817
| -68% | -$2.09M | ﹤0.01% | 2978 |
|
|
2017
Q4 | $3.94M | Buy |
961,137
+49,953
| +5% | +$205K | ﹤0.01% | 2290 |
|
|
2017
Q3 | $4.12M | Sell |
911,184
-55,811
| -6% | -$252K | ﹤0.01% | 2226 |
|
|
2017
Q2 | $3.22M | Buy |
966,995
+286,545
| +42% | +$954K | ﹤0.01% | 2365 |
|
|
2017
Q1 | $6.27M | Buy |
+680,450
| New | +$6.27M | ﹤0.01% | 1866 |
|
|
2014
Q4 | – | Sell |
-15
| Closed | – | – | 5406 |
|
|
2014
Q3 | $0 | Sell |
15
-15
| -50% | – | ﹤0.01% | 6118 |
|
|
2014
Q2 | $1K | Buy |
+30
| New | +$1K | ﹤0.01% | 5479 |
|
|
2013
Q4 | – | Sell |
-13,500
| Closed | -$207K | – | 5903 |
|
|
2013
Q3 | $207K | Buy |
+13,500
| New | +$207K | ﹤0.01% | 3169 |
|